Symptom scores, short acting β2-agonist use, compliance and inhaler technique by off-label prescribing characteristics.
| Children with licensed prescribing (%) | Off-label prescription (%) | χ2 test for trenda (P-value) | |
|---|---|---|---|
| Total number of children | 16 113 | 1050 | |
| Nighttime symptom scoreb | |||
| 0 — None | 8959 (55.6) | 403 (38.4) | |
| 1 — 1–2 per month | 2510 (15.6) | 202 (19.2) | 126.705 |
| 2 — 1–2 per week | 2377 (14.8) | 196 (18.7) | (<0.001) |
| 3 — Daily | 2267 (14.1) | 249 (23.7) | |
| Daytime symptom scoreb | |||
| 0 — None | 6649 (41.3) | 301 (28.7) | |
| 1 — 1–2 per month | 3382 (21.0) | 208 (19.8) | 105.346 |
| 2 — 1–2 per week | 3236 (20.1) | 239 (22.8) | (<0.001) |
| 3 — Daily | 2846 (17.7) | 302 (28.8) | |
| Activity symptom scoreb | |||
| 0 — Rarely | 6925 (43.0) | 347 (33.0) | |
| 1 — Sport | 5919 (36.7) | 361 (34.4) | 87.082 |
| 2 — Active play | 2876 (17.8) | 293 (27.9) | (<0.001) |
| 3 — Walking on flat | 393 (2.4) | 49 (4.7) | |
| Daily short acting β2-agonist useb | |||
| 0 | 9536 (59.2) | 467 (44.5) | |
| 1 | 2014 (12.5) | 132 (12.6) | 93.105 |
| 2 | 2319 (14.4) | 221 (21.0) | (<0.001) |
| >3 | 2244 (13.9) | 230 (21.9) | |
| Poor compliance as assessed by the reviewer | 3200 (19.9) | 208 (19.8) | 1.518 (0.218) |
| Poor inhaler technique as observed at the review | 1735 (10.8) | 109 (10.4) | 0.116 (0.733) |